Metabolic syndrome (MS) is one of the leading risk factors for the development of some
common cancers (endometrial cancer, postmenopausal breast cancer, colorectal cancer) …

Objective. To evaluate the prevalence of metabolic syndrome (MetS) according to the
International Diabetes Federation (IDF) and Adult Treatment Panel (ATP) III criteria among …

Background The PORMETS study was designed to estimate the prevalence of metabolic
syndrome and its determinants in the overall and administrative regions of the Portuguese …

Objective: The objective of the study was to examine the prevalence of metabolic syndrome
among adult Qatari population according to the revised criteria of the National Cholesterol …

Aims We examined, in a country of the African region, i) the prevalence of the metabolic
syndrome (MetS) according to three definitions (ATP, WHO and IDF); ii) the distribution of the …

The clustering of risk factors predisposing an individual to cardiovascular morbidity and
mortality are usually referred to as the 'metabolic syndrome'(MS). Several definitions exist …

Background The prevalence of the metabolic syndrome (MS) has been determined in many
countries worldwide but never in Luxembourg. This research aimed to 1) establish the …

Understanding the factor weighting in the development of metabolic syndrome (MetS) may
help to predict the progression for cardiovascular and metabolic diseases. Thus, the aim of …

Abstract Introduction: Metabolic syndrome affects 20-25% of the adult population globally. It
predisposes to cardiovascular disease and Type 2 diabetes. Studies in other countries …

Background In HIV-infected patients, combination antiretroviral therapy (cART) is associated
with clinical lipodystrophy (CL) and metabolic abnormalities (MA). This study aimed to …